• Providing strategic and technical guidance in all aspects of bioprocessing and biomanufacture including scale-up, scale-down, miniaturization, operations (incl. GMP), market studies.
• Pro-bono/volunteer work for community events and non-profit organizations.

• Biosynthetic Human Breast Milk.
• Provide expertise on strain engineering, protein expression, fermentation, scale-up, protein analysis, glycan analysis.
• Fundraising and business development

• Implemented new screening methods/assays and metabolic engineering strategies.
• Provided expertise to ‘Omics development team and data scientists.
• Managed an international protein engineering and screening project with ILH.
• Managed external collaborations with academic and industry partners.
• Led IP Harvesting.

• Designed and planned GMP-compliant facility for manufacture of skin probiotics.
• Developed budgets; identified key personnel needs; negotiated with vendors.
• Developed cell-based assays (immunological/inflammation).
• Business Development: fundraising, partnerships, market analysis.

• Business Development; New Product Development; Market Research.

• Delivered multiple novel biocatalysts to convert low rank coal and biomass feedstocks into high value chemicals. Used CRISPR, oligo-directed mutagenesis and traditional HR-based methods.
• Developed novel consolidated bioprocesses including the bioconversion of fermentation waste products to usable fuels to power the physical plant. Aerobic and anaerobic process development.
• Provided strategic leadership and personnel management of Metabolic Engineering Department.

• Provided economic and technical analysis and strategic leadership on strain and process development, manufacturing, plant design and business development.
• Established and managed external collaborations with UC Berkeley and a CRO.
• Result: Delivered new P&I and PFD with two new unit ops for retrofitted plant.

• Development and cGMP manufacture of natural products for crop protection and health/beauty.
• Managed 20+ direct and indirect reports in multiple sub-groups.
• Managed departmental budget for all operational and capital costs.
• Upstream development representative for both Global Supply Team (Inatreq®) and Global Business Line Management Team (Spinosyn pesticides).
• Managed external partnership with Meiji Seika Pharma.
• Led the Technical Feasibility Assessment Team.

• Consolidated Bioprocessing for cellulosic ethanol production with proprietary organism.
• Managed group of PhD, Masters and Bachelors level scientists.
• Successfully led the development of a molecular toolbox for Clostridium phytofermentans.
• Responsible for metabolic/genetic engineering strategies, timelines, and project management.
• Utilized transcriptomics, proteomics and metabolomics to determine flux balances.

• Natural products (mostly small molecules) discovery and development for novel pharmaceuticals.
• Managed up to 12 direct reports in three functional groups.
• Managed complex cross-functional timelines and budgets.
• Streamlined and optimized a non-automated screen of Actinomycete libraries, achieving and maintaining a throughput of 1000 colonies per week with a hit rate of 1%.
• Optimized fermentations, automated downstream screening of lead compounds against target organisms.